We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-8.32%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.29B
AUM Growth
-$303M
Cap. Flow
+$76.4M
Cap. Flow %
2.32%
Top 10 Hldgs %
14.37%
Holding
1,576
New
105
Increased
568
Reduced
547
Closed
231

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.9M
2
KMX icon
CarMax
KMX
+$10.9M
3
NFLX icon
Netflix
NFLX
+$7.39M
4
UAL icon
United Airlines
UAL
+$6.3M
5
AMZN icon
Amazon
AMZN
+$5.34M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$6.94M
2
QCOM icon
Qualcomm
QCOM
+$6.76M
3
BHC icon
Bausch Health
BHC
+$5.37M
4
KMI icon
Kinder Morgan
KMI
+$5.15M
5
PLL
PALL CORP
PLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 15.4%
2 Financials 10.61%
3 Consumer Discretionary 9.72%
4 Industrials 9.63%
5 Technology 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
1301
DELISTED
Cantaloupe
CTLP
$53K ﹤0.01%
21,174
-3,710
-15% -$11.6K
LEU icon
1302
Centrus Energy
LEU
$3.48B
$53K ﹤0.01%
17,500
-2,500
-13% -$9.21K
PDLI
1303
DELISTED
PDL BioPharma, Inc.
PDLI
$52K ﹤0.01%
+10,310
New +$59.1K
MMAT
1304
DELISTED
Meta Materials Inc. Common Stock
MMAT
$50K ﹤0.01%
150
+25
+20% +$7.89K
CAMT icon
1305
Camtek
CAMT
$6.18B
$47K ﹤0.01%
18,365
LSTA icon
1306
Lisata Therapeutics
LSTA
$9.02M
$47K ﹤0.01%
209
-406
-66% -$102K
IMMU
1307
DELISTED
Immunomedics Inc
IMMU
$46K ﹤0.01%
26,770
-66,056
-71% -$169K
BIND
1308
DELISTED
BIND THERAPEUTICS INC
BIND
$46K ﹤0.01%
10,500
ARQL
1309
DELISTED
Arqule Inc
ARQL
$43K ﹤0.01%
23,000
-31,000
-57% -$53.5K
CRC
1310
DELISTED
California Resources Corporation
CRC
$43K ﹤0.01%
1,658
+236
+17% +$9.25K
ZNGA
1311
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$42K ﹤0.01%
18,380
-200
-1% -$511
LNCO
1312
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$41K ﹤0.01%
14,967
-1,775
-11% -$7.79K
BTG icon
1313
B2Gold
BTG
$5B
$39K ﹤0.01%
37,000
BNSO
1314
DELISTED
Bonso Electronic International
BNSO
$38K ﹤0.01%
30,000
NRP icon
1315
Natural Resource Partners
NRP
$1.3B
$36K ﹤0.01%
1,415
-1,315
-48% -$38.3K
AMTX icon
1316
Aemetis
AMTX
$106M
$34K ﹤0.01%
+12,415
New +$40.5K
CYTR
1317
DELISTED
CytRx Corp
CYTR
$34K ﹤0.01%
+2,417
New +$40.9K
BAC.WS.B
1318
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$31K ﹤0.01%
108,500
AMD icon
1319
Advanced Micro Devices
AMD
$776B
$29K ﹤0.01%
+16,810
New +$31.6K
FCEL icon
1320
FuelCell Energy
FCEL
$1.73B
$28K ﹤0.01%
9
CLUB
1321
DELISTED
Town Sports International Holdings, Inc.
CLUB
$26K ﹤0.01%
+10,000
New +$25.4K
DRYS
1322
DELISTED
DryShips Inc. Common Stock
DRYS
0
XCO
1323
DELISTED
Exco Resources
XCO
$23K ﹤0.01%
2,000
-333
-14% -$3.67K
PGH
1324
DELISTED
Pengrowth Energy Corporation
PGH
$23K ﹤0.01%
26,128
-3,601
-12% -$5.21K
PSTV icon
1325
Plus Therapeutics
PSTV
$26.6M
0

Similar funds

Oppenheimer & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Oppenheimer & Co held 1,576 positions worth $3.29B, down 8.4% from $3.59B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2015 filing shows 105 new, 568 increased, 547 reduced and 231 closed positions. Its largest new stake was PayPal: 112,571 shares worth $3.49M. The largest sale was ConocoPhillips, an estimated $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Oppenheimer & Co's largest Q3 2015 buy was PayPal: 112,571 shares worth $3.49M.
  • Oppenheimer & Co added most to Gilead Sciences in Q3 2015, an estimated $15.9M increase.
  • Oppenheimer & Co's biggest Q3 2015 reduction was ConocoPhillips, cutting an estimated $6.94M.
  • Oppenheimer & Co fully exited PALL CORP in Q3 2015, selling an estimated $5.04M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.29B portfolio in Q3 2015.
  • Oppenheimer & Co opened 105 new positions and closed 231 in Q3 2015.
  • Oppenheimer & Co's portfolio value fell 8.4% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.